glucose, (beta-d)-isomer has been researched along with Parkinsonian Disorders in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, K; Jin, M; Li, L; Liu, D; Luo, N; Rong, H; Wang, J; Zhang, J; Zhang, X; Zhang, Y | 1 |
| Chen, J; Huang, L; Kang, X; Li, R; Li, T; Sun, X; Yang, Q; Yang, R; Zhang, W | 1 |
| Feng, X; Shi, X; Wang, S; Zhang, S | 1 |
| Haddadi, R; Nadi, F; Poursina, M; Zeraati, F | 1 |
| Chen, J; Chen, L; He, H; Wang, S; Zhang, W; Zhang, X | 1 |
| Dong, MX; Hong, B; Li, XM; Wang, XL; Xing, GH; Zhang, XJ; Zou, Y | 1 |
| Chen, J; Chen, L; He, H; Tang, H; Tian, J; Wang, S; Zhang, W; Zhang, X; Zhao, J | 1 |
| Feng, D; Huang, L; Lai, J; Lu, F; Nie, T; Tao, K; Wang, B; Yang, Q; Zhang, W | 1 |
| Chen, J; Kang, X; Li, X; Liang, Q; Sun, X; Tao, L; Ye, X | 1 |
| Kamitani, T; Matsuo, Y; Usuki, S; Yu, RK | 1 |
| Andersen, RJ; Bains, JS; Cheung, J; Craig, UK; Khabazian, I; Kim, SU; Liu, L; Nagai, A; Pasqualotto, BA; Pelech, SL; Shaw, CA; Wang, YT; Williams, DE; Wilson, JM | 1 |
| Liu, HQ; Luo, XT; Ye, Y; Zhang, WY; Zhu, XZ | 1 |
| Miller, G | 1 |
13 other study(ies) available for glucose, (beta-d)-isomer and Parkinsonian Disorders
| Article | Year |
|---|---|
Neuroprotective effect of paeoniflorin in the mouse model of Parkinson's disease through α-synuclein/protein kinase C δ subtype signaling pathway.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; Annexin A5; Anti-Inflammatory Agents, Non-Steroidal; Antiparkinson Agents; Apoptosis; Disease Models, Animal; Glucosides; Mice; Microscopy, Electron, Transmission; Monoterpenes; Neurotoxins; Parkinsonian Disorders; Protein Kinase C-delta; Rotarod Performance Test; Selegiline; Substantia Nigra | 2021 |
Salidroside protects dopaminergic neurons by regulating the mitochondrial MEF2D-ND6 pathway in the MPTP/MPP
Topics: Animals; Cell Survival; Dopaminergic Neurons; Glucosides; Male; MEF2 Transcription Factors; Mice; Mice, Inbred C57BL; Mitochondria; NADH Dehydrogenase; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders; Phenols; Signal Transduction | 2020 |
Polydatin alleviates parkinsonism in MPTP-model mice by enhancing glycolysis in dopaminergic neurons.
Topics: Animals; Dopaminergic Neurons; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Glucosides; Glycolysis; Male; Mice; Mice, Inbred BALB C; Parkinsonian Disorders; Stilbenes | 2020 |
Gastrodin microinjection suppresses 6-OHDA-induced motor impairments in parkinsonian rats: insights into oxidative balance and microglial activation in SNc.
Topics: Animals; Benzyl Alcohols; Catalepsy; Glucosides; Lipid Peroxidation; Male; Microglia; Microinjections; Nitric Oxide; Oxidation-Reduction; Oxidopamine; Parkinsonian Disorders; Pars Compacta; Peroxidase; Rats; Rats, Wistar | 2018 |
Protective effects of salidroside in the MPTP/MPP(+)-induced model of Parkinson's disease through ROS-NO-related mitochondrion pathway.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cell Survival; Dose-Response Relationship, Drug; Glucosides; Male; Mice; Mice, Inbred C57BL; Mitochondria; Neuroprotective Agents; Nitric Oxide; Oxidative Stress; Parkinsonian Disorders; Phenols; Reactive Oxygen Species; Signal Transduction | 2015 |
Gastrodin prevents motor deficits and oxidative stress in the MPTP mouse model of Parkinson's disease: involvement of ERK1/2-Nrf2 signaling pathway.
Topics: Analysis of Variance; Animals; Ataxia; Benzyl Alcohols; Blotting, Western; DNA Primers; Glucosides; Glutathione; Heme Oxygenase-1; Malondialdehyde; MAP Kinase Signaling System; Mesencephalon; Mice; Molecular Structure; NF-E2-Related Factor 2; Oxidative Stress; Parkinsonian Disorders; Real-Time Polymerase Chain Reaction; Rotarod Performance Test; Spectrophotometry, Ultraviolet; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2014 |
Protective effects of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside in the MPTP-induced mouse model of Parkinson's disease: Involvement of reactive oxygen species-mediated JNK, P38 and mitochondrial pathways.
Topics: Animals; Apoptosis Regulatory Proteins; Behavior, Animal; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Glucosides; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Signaling System; Mice; Mitochondria; Neuroprotective Agents; Parkinsonian Disorders; Phosphorylation; Reactive Oxygen Species; Stilbenes; Tyrosine 3-Monooxygenase | 2015 |
Salidroside Protects Against 6-Hydroxydopamine-Induced Cytotoxicity by Attenuating ER Stress.
Topics: Adrenergic Agents; Animals; Apoptosis; Blotting, Western; Cell Line; Cell Survival; Dopaminergic Neurons; Endoplasmic Reticulum Stress; Glucosides; Immunohistochemistry; In Situ Nick-End Labeling; Mice; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Phenols; Rats; Rats, Sprague-Dawley | 2016 |
Salidroside protects against MPP(+)-induced apoptosis in PC12 cells by inhibiting the NO pathway.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Apoptosis; Glucosides; Membrane Potential, Mitochondrial; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Oxidative Stress; Parkinsonian Disorders; PC12 Cells; Phenols; Rats; Reactive Oxygen Species; Signal Transduction | 2011 |
Pathobiochemical effect of acylated steryl-β-glucoside on aggregation and cytotoxicity of α-synuclein.
Topics: Adenosine Triphosphate; alpha-Synuclein; Amyotrophic Lateral Sclerosis; Cycas; Dementia; Glucosides; Humans; Neurotoxins; Parkinsonian Disorders; Proteostasis Deficiencies; Seeds; Unilamellar Liposomes | 2012 |
Isolation of various forms of sterol beta-D-glucoside from the seed of Cycas circinalis: neurotoxicity and implications for ALS-parkinsonism dementia complex.
Topics: Amyotrophic Lateral Sclerosis; Animals; Astrocytes; Biological Assay; Cells, Cultured; Cerebral Cortex; Cholesterol; Cycas; Dementia; Glucose; Glucosides; Guam; Humans; In Vitro Techniques; Male; Mice; Neurons; Neurotoxins; Parkinsonian Disorders; Patch-Clamp Techniques; Phytosterols; Plant Extracts; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Seeds; Sitosterols; Stigmasterol | 2002 |
Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptor.
Topics: Animals; Benzoates; Bridged-Ring Compounds; Corpus Striatum; Dopamine; Glucosides; Inflammation; Mice; Monoterpenes; Nerve Fibers; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Parkinsonian Disorders; Receptor, Adenosine A1; Substantia Nigra | 2006 |
Neurodegenerative disease. From cycad flour, a new suspect emerges.
Topics: Amyotrophic Lateral Sclerosis; Animals; Cycadopsida; Flour; Glucosides; Guam; Humans; Mice; Neurodegenerative Diseases; Parkinsonian Disorders; Sterols | 2006 |